medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2012, Number 603

<< Back Next >>

Rev Med Cos Cen 2012; 69 (603)

Carcinoma Basocelular

Cajina-Vázquez A

Language: Spanish
References: 26
Page: 325-329
PDF size: 214.63 Kb.


ABSTRACT

Basal cell carcinoma is the most common cancer in humans, especially in caucasians with an increased incidence in different parts of the world. The head is the most common location. Is a result of UV radiation in most cases. Every time you are presenting an increasing incidence in younger populations. The basal cell carcinoma presents different clinical types: Nodular, Pigmented, Superficial, Morfeaforme o Infiltrante o Sclerosing and Fibroepithelioma of Pinkus. It is usually characterized as a locally invasive carcinoma, agressive and destructive but slow growing, with very limited capacity to metastasize. Treatment consists of cirugical removal of the lesion, Mosh Micrographic Surgery, electrodesiccation and curettage. Can also be used cryosurgery and Imiquimod and sometime irradiation.


REFERENCES

  1. Argenziano G, Zalaudek I, Ferrara G, Johr R, Langford D, Puig S, et al. Dermoscopy features of melanoma incognito: indications for biopsy. J Am Acad Dermatol. 2007;56:508-13.

  2. Baccard M, Verola O. Basal cell carcinoma. Ann Dermatol Venereol. 2007; 134:593-4.

  3. Bale AE; Gailani MR, Leffell DJ: Nevoid basal cell carcinoma syndrome. JJ Invest Dermatol 103:126S,1994.

  4. Jaja Bassas-Vila J. Patrones tumorales en dermatopatología (y II) Piel. 2009;24(8):446-50

  5. Benjamin CL, Melnikova VO, Ananthaswamy HN. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:265-82.

  6. Corona R, Dogliotti E, D’Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol. 2001;137:1162-8.

  7. Crowson AN: Basal cell carcinoma: Biology, morphology and clinical implications. Mod Pathol 19 Supl 2: s 127;2006.

  8. Ferrandis C, Fuentes MJ, Ferrández L, Carrascona JM. Basal cell carcinoma. Cancer Treta Res. 2009;146:236-78.

  9. Garces J. ¿Cúales son las indicaciones de la Cirugía de Mohs? Piel. 2010;25 (5):233-235.

  10. Gómez, M Navarra R, Martin M, Abellaneda C, Tapia G. Carcinoma basocelular en semimucosa labial superior. Piel. 2010;25:115-6.

  11. Hidalgo H, Blanco G: Cáncer de piel.. enemigo de los costarricenses. Buena Salud. Colegio de Médicos y Cirujanos Costa Rica 10: 16S, 2010.

  12. Lear JT, Tan BB, Smith AG, Bowers W, Jones PW, Heagerty AH, et al. Risk factors for basal cell carcinoma in the UK: casecontrol study in 806 patients. J R Soc Med. 1997;90:371-4.

  13. Lucas R, McMichael T, Smith W, Armstrong BK, Prüss-Üstün A, World Health Organization. Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation. Geneva: World Health Organization; 2006.

  14. Macaya-Pascuala A, López – Canos R, López- Piqueras S, Gómes S. Ánalisis de los motivos de consulta y su coste en la asistencia dermatológica en un centro de atención primaria, Actas Dermosifiliogr. 2006;97:569-72.

  15. Martín Sánchez MC, et al. Lesiones pigmentadas en la pirámide nasal Piel 2003;18(1):47-9.

  16. 4. Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B.Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol.2000;136:1012-6.

  17. Sánchez G, et al. Factores de riesgo de carcinoma basocelular. Un estudio del Centro Nacional de Dermatología de Colombia. Actas Dermosifiliogr. 2011. doi:10.1016/j.ad.2011.07.012

  18. Sánchez G, et al. Incidencia de cáncer de piel en Colombia años 2003, 2007. Piel. 2011; 26:171-7.

  19. Tarbuk A, Grancaric AM, Situm M, Martinis M. UV clothing and skin cancer. Coll Antropol. 2010;34 Suppl 2:179-83.

  20. Tejera-Vaquerizo A, Huertas-Aguayo M, Perez I, Illescas-Estévez M. Estudio de los motivos de consulta adicionales en la consulta ambulatoria de dermatología. Piel. 2008;23:540-3.

  21. Valcayo A, Vives R, Artal F, Eciolaza JM, Parra A, Bernués C, et all. Frecuentación de las consultas de atención primaria por motivos dermatológicos en las zonas básicas de salud de Pamplona. ANALES Sis San Navarra. 1999; 22:173-9.

  22. Vlajinac HD, Adanja BJ, Lazar ZF, Bogavac AN, Bjekic MD, Marinkovic JM, et al. Risk factors for basal cell carcinoma. Acta Oncol. 2000;39:611-6.14.

  23. Walther U, Kron M, Sander S, Sebastian G, Sander R, Peter RU, et al. Risk and protective factors for sporadic basal cell carcinoma: results of a twocentre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol. 2004;151:170-8.

  24. Wolff K, Goldsmith L, Katz S, et all. Fitzpatrick: Dermatología en Medicina General ; 7a ed- Buenos Aires: Médica Panamericana, 2009. v 2:1036-1042 .

  25. Wolff K, Johnson RA. Fitzpatrick: Atlas de Color y sinopsis de dermatología clínica; 6a ed- Buenos Aires: Médica Panamericana, 2010: 287-294.

  26. Zahnd WE, Goldfarb J, Scaife SL, Francis ML. Rural-urban differences in behaviors to prevent skin cancer: an analysis of the Health Information National Trends Survey. J Am Acad Dermatol. 2010;62:950-6.




2020     |     www.medigraphic.com